Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type Metastatic Colorectal Cancer: A Single-center, Prospective Phase Ib/II Study
Latest Information Update: 25 Apr 2024
At a glance
- Drugs Cetuximab (Primary) ; Tipiracil/trifluridine (Primary)
- Indications Adenocarcinoma; Colon cancer; Colorectal cancer
- Focus Therapeutic Use
- 25 Apr 2024 New trial record